CITIVA, in collaboration with the University of West Indies, Mona announced today they are donating the first cannabis-based medicine extracted from their well-researched, high-CBD cannabis strain, to be used in a ground-breaking study in Jamaica that will examine its effect on children with Epilepsy. 

"As Jamaica moves forward to embrace the cannabis industry, we are pleased and honored to provide to CITIVA the most advanced technological extraction of phytocannabinoids, to ensure and guarantee that their finished products are accurately dosed, and of the highest standards of quality and purity," said Karibe McKenzie, Founder and CEO of Epican. The specialized, therapeutic, High-CBD strain, which was bred and cultivated by CITIVA at their horticulture center on the MONA campus was safely and successfully extracted into oil by Epican at their 5000 sq. ft., state-of-the-art facility in Kingston.  Epican, a Jamaican-owned and operated company is partnering with the Scientific Research Council with focus on large scale, CO2 extraction of phytocannabinoids and terpenes from the cannabis plant for medicinal purposes. Epican's extraction equipment is supplied through a relationship with MetaCan, a US company, with over a decade of experience in developing novel and proprietary extraction technologies specifically for the cannabis industry. 

Both companies have been engaged in local collaborative research agreements and are working...